An early analgesic advantage did not translate into a demonstrated difference in the twenty-four-hour total.
The randomized gastrectomy study compared target-controlled sufentanil and remifentanil within remimazolam-based anesthesia guided by processed monitoring. The sufentanil group used less fentanyl in the first thirty postoperative minutes and had lower pain scores during the first hour. Cumulative fentanyl over twenty-four hours, extubation, recovery-unit stay and first-day quality-of-recovery scores were comparable.
Both groups received remimazolam, so the study cannot isolate its analgesic contribution. It tested particular low opioid targets at one institution with a limited sample. Pain and consumption beyond the first day were not evaluated, and specific functional respiratory outcomes were not prospectively recorded. Similar later totals do not mean the early symptom pattern was identical.
When reviewing rescue medication, retain its timing instead of relying only on a daily total. A patient may have a different immediate recovery experience even when cumulative consumption converges. Conversely, early opioid sparing does not establish durable recovery or fewer respiratory complications. This source is useful for reconstructing how an opioid component changes a benzodiazepine-based anesthetic package, with each drug’s contribution and observation window kept explicit.
Source: PMC12733775, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Cardiac-Catheterization Sedation Crossovers Matter When Comparing Fentanyl Use.